In a Nov. 18 post, Ms. Nelson shared three reasons why ASCs are threatening future HOPD market share:
1. CMS expanded the number of ASC-payable surgical procedures to include total knee arthroplasty, as well as some neurosurgery and cardiology services.
2. CMS’ site-neutral payment policies are shrinking the reimbursement gap between ASCs and HOPDs.
3. The rise in high-deductible insurance options is making patients more price-sensitive, and co-pays tend to be lower in ASCs than in HOPDs.
More articles on surgery centers:
10 recent ASC leadership moves
Virginia ASC takes infection prevention to new level — 3 insights
Surgery Partners goes all-in on cardiology — 5 quotes on its quarterly performance
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
